Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
News

Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr

The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021

  • By IPP Bureau | May 23, 2021

Orchid Pharma has reported total income of Rs.130.84 crores during the period ended March 31, 2021 as compared to Rs.104.52 crores during the period ended December 31, 2020. The company reported total income of Rs.92.77 crores during the period ended March 31, 2020.

Orchid Pharma has posted net loss of Rs. (24.72) crores for the period ended March 31, 2021 as against net loss of Rs.(44.72) crores for the period ended December 31, 2020.The company posted net loss of Rs.(38.85) crores for the period ended March 31, 2020.

The company has reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021 as compared to Rs.508.07 crores during the 12 months period ended March 31, 2020.

The company has posted net loss of Rs.(116.53) crores for the 12 months period ended March 31, 2021 as against net loss of Rs.(131.07) crores for the 12 months period ended March 31, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization